The 11 runtime attacks breaking AI security — and how CISOs are stopping them

CrowdStrike's 2025 data shows attackers breach AI systems in 51 seconds. Field CISOs reveal how inference security platforms ...
Seeking Alpha

Recursion jumps as J.P. Morgan upgrades on lead program

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...
pharmaphorum

AI biotechs Exscientia and Recursion agree $688m merger

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Hosted on MSN

Recursion Pharmaceuticals upgraded to overweight from neutral at JPMorgan

JPMorgan upgraded Recursion Pharmaceuticals (RXRX) to Overweight from Neutral with a price target of $11, up from $10. The firm says the company’s REC-4881 has shown “strong and durable” efficacy in ...
IEEE

Recursive Gaussian Process-Based Safety Assurance Exploration Control in Unknown Environments

Abstract: This letter presents a novel method for environmental exploration that takes safety into account in unknown areas by using recursive Gaussian process regression (RGPR). Safety in unknown ...
IEEE

Disturbance Detection in Power Quality Data using Principle Component Analysis, Recursive Feature Elimination and Logistic Regression

Abstract: This paper introduces an innovative approach to classify disturbances in power quality (PQ) by combining principal component analysis (PCA), recursive feature elimination (RFE) and logistic ...
Barron's

Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...